John Roback to Hematopoietic Stem Cell Transplantation
This is a "connection" page, showing publications John Roback has written about Hematopoietic Stem Cell Transplantation.
Connection Strength
0.108
-
Peritransplantation Red Blood Cell Transfusion Is Associated with Increased Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant. 2018 05; 24(5):973-982.
Score: 0.066
-
Flagellin, a TLR5 agonist, reduces graft-versus-host disease in allogeneic hematopoietic stem cell transplantation recipients while enhancing antiviral immunity. J Immunol. 2011 Nov 15; 187(10):5130-40.
Score: 0.043